Bicara Therapeutics Inc. Payments to Acquire Investments
Bicara Therapeutics Inc. (BCAX) reported Payments to Acquire Investments of $318.17 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2026-03-30
- Bicara Therapeutics Inc. payments to acquire investments for the quarter ending 2025-12-31 was $82.09M.
- Bicara Therapeutics Inc. payments to acquire investments for the quarter ending 2024-12-31 was $0.00.
- Bicara Therapeutics Inc. payments to acquire investments for fiscal 2025 was $318.17M.
- Bicara Therapeutics Inc. payments to acquire investments for fiscal 2024 was $0.00.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|
| 2025-12-31 | $82.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $318.17M 10-K · filed 2026-03-30 | |
| 2025-09-30 | $236.08M 10-Q · filed 2025-11-10 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 10-K · filed 2026-03-30 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B |